Exploring the variations in dementia presentations and Singapore’s progress in dementia research.
Dementia affects millions worldwide, and understanding its presentation across different populations is crucial for early intervention and treatment. In this episode, Professor Nagaendran Kandiah, director of the Dementia Research Centre (Singapore) at Nanyang Technological University, discusses how dementia manifests differently in Asian and Caucasian populations. These variations have implications for diagnosing and treating the disease, especially in terms of genetic factors, lifestyle, and cultural aspects.
Professor Kandiah also addresses the role of innovative drugs like Lecanemab and Donanemab in slowing Alzheimer’s disease. These drugs work by targeting the root causes of Alzheimer’s, with Donanemab already approved in certain regions, though not yet recommended for the National Health Service in England. Furthermore, advancements in diagnostic tools, such as blood tests for early detection of dementia, are also explored, offering hope for more proactive treatment strategies in the future.
The episode sheds light on the latest developments in dementia research in Singapore, emphasizing the importance of tailored approaches to address the unique needs of both Asian and Caucasian populations.
